L-
Haasis III is a board-certified Pain Management Anesthesiologist with over 25 years of experience
Effect on cardiac ischemia and cardiac outcomes L-carnitines theoretical benefit in improving clinical outcomes, particularly after ischemic events and cardiac surgeries, is well-established
Investment in Your Health Transparent pricing designed for sustainable results
On June 27, 2025, Innovent Biologics, Inc., a leading biopharmaceutical company focused on developing, manufacturing, and commercializing high-quality medicines for oncology, autoimmune, cardiovascular, and metabolic diseases, announced that China's National Medical Products Administration (NMPA) approved Mazdutide, the worlds first dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, for chronic weight management in Chinese adults with overweight or obesity